• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Treat NMD Logo (Copyright)

TREAT-NMD

Advancing diagnosis, care and treatment for people with neuromuscular diseases around the world

Contact us

header-right

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
  • What We Do
    • Advisory Committee for Therapeutics
    • The Global Registry Network
    • Core Datasets
    • Education
    • Post-Marketing Surveillance
  • Resources and Support
    • Neuromuscular Disease Information
    • Research Overview
    • Standards of Care & Family Guides
    • SOP Library
    • Social and Ethical Issues
  • Conference
    • Registration
    • Sponsorship Opportunities
    • Conference Programme
    • Sponsors of the TREAT-NMD 8th International Conference
    • Programme Committee
    • Abstracts
    • Venue
  • News & Events
    • News
    • TREAT-NMD Events
    • All Events
    • Submit an Event
    • Newsletter Sign-up
    • Contact Us

Advisory Committee for Therapeutics

Home / What We Do / Advisory Committee for Therapeutics

Advisory Committee for Therapeutics

The TREAT-NMD Advisory Committee for Therapeutics (TACT) is a unique multi-disciplinary group of international experts including: academic and industry drug development experts, representatives of patient foundations, and regulatory bodies. TACT takes on the challenge of evaluating the therapeutic potential of drugs across neuromuscular diseases including acquired and genetic motor neuron, neuromuscular junction, peripheral nerve, and muscle diseases. TACT aims to apply the learnings from previous experience to optimise drug design and development programmes by providing a comprehensive, confidential review containing constructive feedback and guidance.

 TACT can address: 

  • Trial design. 
  • Drug formulation. 
  • Bioavailability and toxicology.
  • Regulatory and marketing considerations.
  • Recommendations including go-no-go milestones.  

The TACT meets twice a year: once in the autumn and once in the spring.   Applicants are asked to pay a contribution towards the meeting costs based on their stage of development and investment raised.  Fees are scaled to reflect the level of support required to make TACT sustainable whilst factoring in the applicant’s financial capacity.

The TACT process is independent of any funding stream, but applicants often use its reports to support funding applications. A TACT review is NOT an endorsement by TACT or TREAT-NMD that a drug has any particular status in terms of regulatory or funding potential.  

TACT news

Past Applications by Disease Area

TACT publications

  • Improving translatability of preclinical studies for NMD – click here
  • TACT: an innovative de-risking model to foster orphan drug development – click here
  • A decade of optimizing drug development – click here

Upcoming Advisory Committee Meetings

Summer 2025, Virtual Meeting

Full

July 29th 2025

Autumn 2025, Atlanta, USA

One Place Available

November 7th – 9th 2025

Spring 2026, European location TBC

Four Places Available

April 24th – 26th 2026

Ad Hoc Virtual Meetings

Please get in touch to find out if we can accommodate a virtual meeting: info@treat-nmd.com.

Virtual meetings are subject to approval and availability of the TACT core committee

TACT Terms of Reference

Interested in coming to TACT?

Get in touch with us at info@treat-nmd.com to talk about how we can help improve your therapeutic development programme. 

Primary Sidebar

  • What We Do
  • Advisory Committee for Therapeutics
    • Advisory Committee for Therapeutics
    • Members of the Advisory Committee for Therapeutics
    • Past Applicants
    • Advisory Committee for Therapeutics FAQs
  • Global Registry Network
    • The Global Registry Network
    • Global Data systems Oversight Committee – TGDOC
    • Members of the Registry Network
  • Core Datasets
    • Core Datasets
    • DM dataset
    • DMD dataset
    • FSHD dataset
    • LGMD dataset
    • SMA dataset
  • Education
    • Education
    • Masterclasses and Events
    • Sponsors of the TREAT-NMD 8th International Conference
    • Digital Resources
    • Endorsement of External Programmes
  • Post-Marketing Surveillance
    • Post-Marketing Surveillance
    • STRIDE Registry

Footer

Contact us

4th Floor
The Catalyst
Newcastle upon Tyne
NE4 5TG
United Kingdom
info@treat-nmd.com

Links

Home
Who we are
What we do
Who we support
Resources & support
Connect with us
Privacy Policy
Cookies

Newsletter Sign Up

Sign up to our monthly newsletter

 
ISO 27001 Accreditation Logo

Connect

info@treat-nmd.com
TREAT NMD © 2025
Privacy Policy
Sitemap
STCS LTD

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
  • What We Do
    • Advisory Committee for Therapeutics
      • Members of the Advisory Committee for Therapeutics
      • Take Part in TACT
      • Past Applicants
    • The Global Registry Network
      • Members of the Registry Network
    • Core Datasets
      • DM dataset
      • DMD dataset
      • FSHD dataset
      • LGMD
      • SMA
    • Education
      • Masterclasses and Events
      • Digital Resources
      • Endorsement of External Programmes
    • Post-Marketing Surveillance
  • Resources and Support
    • Neuromuscular Disease Information
      • Becker muscular dystrophy
      • Charcot-Marie-Tooth
      • Congenital muscular dystrophy
      • Congenital myasthenic syndromes
      • Duchenne muscular dystrophy
      • Facioscapulohumeral muscular dystrophy
      • GNE myopathy
      • Limb girdle muscular dystrophy
      • Myotonic dystrophy
      • Myotubular and centronuclear myopathies
      • Spinal muscular atrophy
    • Research Overview
      • DMD
        • Gene Therapy for DMD
        • Mutation Specific Approaches
        • Cell Therapy
        • Drug Therapy
    • Standards of Care & Family Guides
      • CM Care
      • CMD Care
      • DM Care
      • DMD Care
      • BMD Care
      • FSHD Care
      • SMA Care
    • SOP Library
      • MDX Mouse (DMD)
      • GRMD Dog (DMD)
      • CMD Mouse (CMD)
      • SMA Mouse (SMA)
      • CMD animal models
      • MDC1A Preclinical Research
      • Cell Lines
        • Clinical Outcome Measures
        • Functional Evaluation Tools
        • NMR (MRI/MRS) Imaging
        • Muscle Biopsy
    • Social and Ethical Issues
  • Conference
    • Registration
    • Sponsorship Opportunities
    • Conference Programme
    • Sponsors of the TREAT-NMD 8th International Conference
    • Programme Committee
    • Abstracts
    • Venue
  • News & Events
    • News
    • TREAT-NMD Events
    • All Events
    • Submit an Event
    • Newsletter Sign-up
    • Contact Us